The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 05, 2009
Filed:
Feb. 28, 2007
Amir Toporik, Azur, IL;
Dvir Dahary, Tel-Aviv, IL;
Rotem Sorek, Rechovot, IL;
Sarah Pollock, Tel-Aviv, IL;
Zurit Levine, Herzlia, IL;
Pinchas Akiva, Ramat-Gan, IL;
Alexander Diber, Richon-LeZion, IL;
Amit Novik, Beit-Ha-Sharon, IL;
Osnat Sella-tavor, Kfar Kish, IL;
Michal Ayalon-soffer, Ramat-HaSharon, IL;
Shira Walach, Hod-HaSharon, IL;
Shirley Sameah-greenwald, Kfar-Saba, IL;
Ronen Shemesh, Modiln, IL;
Naomi Keren, Givat Shmuel, IL;
Maxim Shklar, Tel-Aviv, IL;
Amir Toporik, Azur, IL;
Dvir Dahary, Tel-Aviv, IL;
Rotem Sorek, Rechovot, IL;
Sarah Pollock, Tel-Aviv, IL;
Zurit Levine, Herzlia, IL;
Pinchas Akiva, Ramat-Gan, IL;
Alexander Diber, Richon-LeZion, IL;
Amit Novik, Beit-Ha-Sharon, IL;
Osnat Sella-Tavor, Kfar Kish, IL;
Michal Ayalon-Soffer, Ramat-HaSharon, IL;
Shira Walach, Hod-HaSharon, IL;
Shirley Sameah-Greenwald, Kfar-Saba, IL;
Ronen Shemesh, Modiln, IL;
Naomi Keren, Givat Shmuel, IL;
Maxim Shklar, Tel-Aviv, IL;
Compugen Ltd, Tel Aviv, IL;
Abstract
Novel markers for breast cancer that are both sensitive and accurate. These markers are overexpressed in breast cancer specifically, as opposed to normal breast tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of breast cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between breast cancer and non-cancerous states.